Immunohisochemical Studies on Expression of Estrogen Receptor Related Protein ( ERD5 ) in Gastric Cancer.
- Author:
Hong Jun GO
1
;
Byeong Do HEO
;
Shin SON
;
Chang Gn JEONG
;
Young Hyeon CHO
;
Yeong Jun LEE
;
Jong Yeon JANG
;
Woo Song HA
Author Information
1. Department of Surgery, College of Medicine, and Gyeongsang Institute of Cancer Research, Gyeong-Sang National University and Hospital, Chinju, Korea.
- Publication Type:Original Article
- Keywords:
Gastric cancer;
ERD5 ERD5 Immunohistochemistry
- MeSH:
Age Distribution;
Classification;
Estrogens*;
Female;
Humans;
Kaplan-Meier Estimate;
Male;
Neoplasm Staging;
Paraffin;
Sex Distribution;
Stomach Neoplasms*;
Survival Rate
- From:Journal of the Korean Surgical Society
1997;52(1):28-36
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
To evaluate the prognostic significance of ERD5 in gastric cancer, the frequency of their expression was examined by the immunohistochemical method in 70 cases of gastric cancer with alcohol-fixed, paraffin embedded specimens which were obtained surgically at the department of Surgery, Gyeongsang National University Hospital from October, 1990 to May, 1993. Correlations between ERD5 positivity and clinicopathological parameters were analysed with Student's t-test and Chi-square test, and the survival rate according to whether the ERD5 was present or not was evaluated with Kaplan-Meier analysis model. Of the 70 patients, 40 cases showed a positive rate for estrogen receptor and 27 cases(67.5%) were male and 15 cases(50%) were female. There was no significant difference between the ERD5 positive rate and sex distribution. In age distribution, the ERD5 positive rate was most high(67%) in the 5th decade, but it was not significant statistically. There was no significant difference between the ERD5 positive rate and the WHO pathologic classification. In Lauren's classification, the intestinal type of gastric cancer had a higher positive rate(69%) than diffuse type(50%). In Ming's classification, the expanding type(82%) of gastric cancer had a higher positive rate than the infiltrative type(50%). A statistically significant difference was found between the expanding type and infiltrative type(P<0.05). There were no significant differences between the ERD5 positive rate and the TNM staging or the degree of differentiation of cancer cells. There was no significant difference between the ERD5 positive rate and the serum CEA level. Of the 70 patients, the overall 5-years survival rate was 37 % and 5-years survival rate of positive ERD5 cases had a higher rate (38.4%) than negative cases (35.1%) but there was no statistically significant difference. In conclusion, the ERD5 positive rate was significantly high in the patient with expanding type of gastric cancer in Ming's classification and intestinal type of gastric cancer in Lauren's classification. But, there was no significant difference in the survival rates between the ERD5 positive group and the ERD5 negative group.
